Arranta Bio is focused on providing process development and cGMP manufacturing CDMO services for live biotherapeutic products (LBPs) targeting diseases linked to the human microbiome.
With a range of platform technologies, we are executing our business plan to rapidly grow infrastructure and capabilities to meet the needs of innovator companies in this exciting area.
Building on the foundation of Captozyme, our team brings 10 years of experience with CDMO services and developing processes for LBPs at our cGMP facility in Gainesville, Florida, where we offer process development and early clinical supply. We are also establishing a larger cGMP facility in Watertown, Massachusetts that will provide late-stage clinical and commercial supply.
Our cGMP facility in Gainesville, Florida brings 10 years of experience in the development and supply of LBPs, and we are working on bringing online our commercial-ready facility in Watertown, Massachusetts.